Bacteriological evaluation of vaccination against Salmonella Typhimurium with an attenuated vaccine in subclinically infected pig herds by Peeters, Linda et al.
Contents lists available at ScienceDirect
Preventive Veterinary Medicine
journal homepage: www.elsevier.com/locate/prevetmed
Bacteriological evaluation of vaccination against Salmonella Typhimurium
with an attenuated vaccine in subclinically infected pig herds
L. Peetersa,*, J. Dewulfa, F. Boyenb, C. Brosséc, T. Vandersmissenc, G. Rasschaertd,
M. Heyndrickxb,d, M. Cargnele, W. Mattheuse, F. Pasmansb, F. Haesebrouckb, D. Maesa
a Faculty of Veterinary Medicine, Department of Reproduction, Obstetrics and Herd Health, Ghent University, Merelbeke, Belgium
b Faculty of Veterinary Medicine, Department of Pathology, Bacteriology and Avian Diseases, Ghent University, Merelbeke, Belgium
cAnimal Health Care Flanders (DGZ), Lier, Belgium
d Flanders Research Institute for Agriculture, Fisheries and Food (ILVO), Melle, Belgium
e Sciensano, Brussels, Belgium






A B S T R A C T
Subclinical infections with Salmonella Typhimurium occur frequently in pigs. They constitute a risk for human
salmonellosis and are difficult to control with currently available control measures. Vaccination against
Salmonella Typhimurium in pigs can be an effective tool to control Salmonella infections at farm level.
In the present study, the efficacy of an attenuated Salmonella Typhimurium vaccine (Salmoporc®, IDT
Biologika) to control Salmonella infections in pigs was evaluated in three subclinically infected pig herds. The
effect on Salmonella excretion and the number of pigs positive for Salmonella Typhimurium field and vaccine
strains in ileocecal lymph nodes at slaughter were evaluated using five different vaccination strategies: 1.
vaccination of sows, 2. vaccination of sows and piglets, 3. vaccination of sows and fattening pigs, 4. vaccination
of piglets, 5. vaccination of fattening pigs, which were all compared to a non-vaccinated control group (ex-
perimental group 6). Each vaccination strategy was implemented in each farm, during two consecutive pro-
duction cycles of the same sows.
The prevalence of Salmonella Typhimurium field strain excretion was low; in total, 4% of the fecal and
overshoe samples collected in the non-vaccinated control group were Salmonella Typhimurium field strain po-
sitive. The excretion of Salmonella Typhimurium field strain did not significantly differ between farms, pro-
duction cycles and experimental groups. Applying vaccination in either sows and piglets, sows and fattening
pigs, or in piglets only, resulted in a significantly reduced number of Salmonella Typhimurium field strain po-
sitive lymph nodes of slaughter pigs in the second production cycle, but not in the first production cycle.
Vaccination of sows and piglets resulted in the most consistent reduction of Salmonella Typhimurium field strain
positive lymph nodes at slaughter. The vaccine strain was detected in the lymph nodes of 13 pigs at slaughter,
indicating the possible persistence of the vaccine strain until slaughter.
Because of limitations in the study design, and the variability between farms and production cycles, the
results of the current observational study should be extrapolated with care. Nevertheless, the results provide
evidence that applying vaccination against Salmonella Typhimurium in sows and piglets (preferred), sows and
fattening pigs, and piglets only can support the control of Salmonella Typhimurium infections by decreasing the
prevalence of Salmonella Typhimurium field strain positive lymph nodes at slaughter.
1. Introduction
Human salmonellosis is the second most reported foodborne zoo-
nosis in Europe (EFSA, 2015b,a, 2016, 2017). Infections with Salmo-
nella enterica subspecies enterica serovar Typhimurium (Salmonella
Typhimurium) in pigs constitute a major risk for human salmonellosis.
In 2016, pigs and pork were considered the source of 26.9% of the
human infections caused by Salmonella Typhimurium and of 61.9% of
the human infections caused by Salmonella Typhimurium monophasic
variants (EFSA, 2017).
https://doi.org/10.1016/j.prevetmed.2019.04.016
Received 20 January 2019; Received in revised form 28 April 2019; Accepted 28 April 2019
⁎ Corresponding author at: Ghent University, Faculty of Veterinary Medicine, Department of Reproduction, Obstetrics and Herd Health, Unit Porcine Health
Management, Salisburylaan 133, 9820, Merelbeke, Belgium.
E-mail address: Linda.Peeters@UGent.be (L. Peeters).
Preventive Veterinary Medicine 169 (xxxx) xxxx
0167-5877/ © 2019 Elsevier B.V. All rights reserved.
T
Please cite this article as: L. Peeters, et al., Preventive Veterinary Medicine, https://doi.org/10.1016/j.prevetmed.2019.04.016
The high prevalence of subclinical infections with Salmonella
Typhimurium in pig herds, together with the intermittent shedding
pattern of infected pigs and the common occurrence of carriers and
environmental reservoirs, hamper a proper control of infections at farm
level (Gray and Fedorka-Cray, 1996; Funk et al., 2001; Pires et al.,
2013; Lynch et al., 2018). Current on-farm control measures are mainly
focused on biosecurity, cleaning and disinfection, all-in all-out man-
agement and acidification of feed and drinking water (Wales et al.,
2011; Andres and Davies, 2015; Callegari et al., 2015; Hill et al., 2016).
Vaccination against Salmonella in pigs can be an important tool to
control Salmonella infections at farm level as well (Denagamage et al.,
2007; de la Cruz et al., 2017; Wales and Davies, 2017).
The main goals of vaccination are to prevent clinical salmonellosis,
to decrease shedding and colonization and to decrease the probability
of contamination of carcasses (Haesebrouck et al., 2004; Meeusen et al.,
2007; Boyen et al., 2008; Arguello et al., 2012; Wales and Davies,
2017). Several papers report beneficial effects of different vaccines
against Salmonella infection in pigs, either under experimental or field
conditions (Denagamage et al., 2007; de la Cruz et al., 2017; Wales and
Davies, 2017). Most studies measured vaccine efficacy by comparing
the presence of Salmonella in feces and/or organs between vaccinated
and control groups (de la Cruz et al., 2017), additionally, the effect on
weight gain is evaluated in several studies (Farzan and Friendship,
2010; De Ridder et al., 2014).
The attenuated histidine-adenine auxotrophic vaccine Salmoporc®
(IDT Biologika) is currently the only Salmonella Typhimurium vaccine
commercially available for pigs in Europe. The vaccine has previously
been evaluated with promising results in sows and weaned piglets of
three and six weeks of age (Lindner et al., 2007), in piglets of three and
24 days of age (Roesler et al., 2010; De Ridder et al., 2014), in weaned
piglets of four and seven weeks of age (Theuß et al., 2017) and in sows
and gilts (Davies et al., 2016; Smith et al., 2018). To our knowledge, the
vaccine has not been evaluated in a field study applying several dif-
ferent vaccination strategies in one farrowing batch. Also, the vaccine
has not yet been evaluated in fattening pigs at the start of the fattening
period. Vaccination of fattening pigs may be beneficial compared to
vaccination around weaning, as it avoids extra handling, stress and
possible adverse reactions in the crucial transition period around
weaning.
The general aim of the present study was to assess the effect of
different vaccination strategies (1. vaccination of sows, 2. vaccination
of sows and piglets, 3. vaccination of sows and fattening pigs, 4. vac-
cination of piglets, 5. vaccination of fattening pigs) with an attenuated
Salmonella Typhimurium vaccine in subclinically infected pig herds.
The specific objectives were: 1. to investigate the effect of the different
vaccination strategies on the excretion of Salmonella Typhimurium field
strains, 2. to investigate to which extent the different vaccination
strategies reduce the number of pigs positive for Salmonella
Typhimurium field strains in the ileocecal lymph nodes at slaughter, 3.
to evaluate the possible persistence of the vaccine strain in ileocecal
lymph nodes, 4. to evaluate the genetic variation between Salmonella
Typhimurium isolates originating from vaccinated and non-vaccinated
pigs and 5. to evaluate the effect of the different vaccination strategies
on the daily weight gain during the fattening period.
2. Materials & methods
2.1. Farm selection
Three Belgian pig farms (A, B, C) were selected based on the fol-
lowing criteria: 1. bacteriological detection of Salmonella Typhimurium
on the farm and high Salmonella-specific antibody levels in fattening
pigs (S/P-ratios ≥0.6) in the former Belgian Salmonella Surveillance
Program, without clinical Salmonella infections during the year pre-
ceding the study, 2. a minimum of 72 sows per farrowing batch, 3.
possibility to monitor the pigs from birth to slaughter, 4. willingness of
the farmer to participate in the study. Based on a list of possibly suitable
farms, farms were contacted to explain the study and visited to evaluate
if all criteria were met. The presence of Salmonella Typhimurium was
confirmed by bacteriological analysis (as described below) of overshoe
samples taken at the farm or ileocecal lymph nodes collected at the
slaughterhouse before onset of the study.
2.1.1. Description of the selected farms
A general description of the selected farms is shown in Table 1.
Farm A and C were farrow-to-finish farms, farm B was a multiplier herd.
All farms practiced a 4-week batch production system for the sows. The
fattening stables of farm A were at the same location as the sow herd,
whereas the fattening pigs of farms B and C were transported to fat-
tening stables located at a different site than the sow herd at 10 weeks
of age.
2.2. Experimental design
In each farm, one batch of sows was selected, from which 72 sows of
different parities were randomly allocated to six experimental groups,
each consisting of 12 sows and their offspring. Five different vaccina-
tion strategies were applied: 1. vaccination of sows, 2. vaccination of
sows and piglets, 3. vaccination of sows and fattening pigs, 4. vacci-
nation of piglets, 5. vaccination of fattening pigs. These five experi-
mental groups were compared to a non-vaccinated control group (ex-
perimental group 6). The study started in spring 2015 (farm A and B)
and spring 2016 (farm C). The sows were monitored during two con-
secutive production cycles and their piglets were followed from birth
until slaughter.
An attenuated histidine-adenine auxotrophic vaccine (Salmoporc®,
Table 1
General description of the three selected pig farms.
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IDT Biologika) was used for all vaccinations. For each dose, one mL of
vaccine was administered. In sows, the vaccine was applied sub-
cutaneously, at six and three weeks before farrowing in the first pro-
duction cycle and at three weeks before farrowing in the second pro-
duction cycle. Replacement gilts in experimental groups 1, 2 and 3
(n=40, 2–7/experimental group/farm), in the second production
cycle, were vaccinated six and three weeks before farrowing. In piglets,
the vaccine was administered orally twice, at three and 24 days of age.
Fattening pigs were vaccinated subcutaneously twice, at 11–12 and
14–15 weeks of age. The administration of antimicrobials was pro-
hibited from five days before until five days after vaccination.
To minimize possible transmission of the vaccine strain and to avoid
differences in excretion patterns between the different experimental
groups to influence the results, all experimental groups were separated
as much as possible. In the farrowing house, transfer of piglets to an-
other sow was only allowed within the experimental group. During the
nursery and fattening period, the pigs of each experimental group were
housed in separate pens within the same room. Nose-to-nose-contact
with pigs from other experimental groups was possible in all fattening
stables, and in the nurseries of farm C. During transport to the
slaughterhouse and in the lairage area, it was not possible to strictly
separate the different experimental groups.
2.3. Sampling design
The study was approved by the ethical committee of the Faculty of
Veterinary Medicine, Ghent University (EC 2015/06).
2.3.1. Excretion: fecal and overshoe samples
In the first production cycle, individual rectal fecal samples from all
sows were collected six weeks before farrowing, three days after far-
rowing, in the second week after farrowing and 3–5 days after weaning.
In the gestation unit (six weeks before farrowing) and in the in-
semination unit (3–5 days after weaning), 2–9 overshoe samples/farm
(depending on the housing of the sows, e.g. number of pens with en-
rolled sows in the gestation unit and layout of the insemination unit)
were collected. In the farrowing unit (three days after farrowing and in
the second week after farrowing), two overshoe samples/experimental
group/farm were collected. In the nursery, at 24 days of age and at the
end of the nursery period (approximately 10 weeks of age), two over-
shoe samples/experimental group/farm were collected. In the fattening
stables, five overshoe samples/experimental group/farm were collected
at 11–12, 14–15, 18 and 26 weeks of age. Individual rectal fecal sam-
ples from 10 fattening pigs/experimental group/farm were collected at
18 and 26 weeks of age.
In the second production cycle, two overshoe samples/experimental
group/farm were collected three days after farrowing and at 24 days of
age. At 26 weeks of age, five overshoe samples/experimental group/
farm were collected, as well as individual rectal fecal samples of 10
pigs/experimental group/farm.
2.3.2. Ileocecal lymph nodes
As many as possible ileocecal lymph nodes per experimental group/
farm/cycle were collected during slaughter and transported to the la-
boratory under cooled conditions. Because of practical reasons, all
lymph nodes were frozen at −20 °C until the analysis. The slaughter-
houses, approximate distance from farm to slaughterhouse and the
approximate transport and lairage times (collected from the farmers
and slaughterhouse employees) are shown in Table 1.
Based on sample size calculations (WinEpi.net), the aim was to
collect at least 70 ileocecal lymph nodes per experimental group/farm/
cycle (in total, 210 ileocecal lymph nodes per experimental group/
cycle). This sample size enabled the detection of a reduction of 10% in
the prevalence of Salmonella Typhimurium in ileocecal lymph nodes
with a confidence level of 95% and a power of 80%. When the pre-
valence would be reduced from 20% to 10% or from 15% to 5%, the
required sample size was 198 or 139 animals per experimental group,
respectively. The expected prevalence used for the sample size calcu-
lations was based on previous studies on Belgian farrow-to-finish herds,
collecting (ileocecal or mesenteric) lymph nodes for Salmonella culture
(Nollet et al., 2005; De Ridder et al., 2014).
2.4. Daily weight gain during fattening period
The pigs were weighed individually at 10–12 weeks of age and
24–26 weeks of age. To determine the individual daily weight gain, the
total weight gain was divided by the number of days in between the two
weighing moments.
2.5. Bacteriological analysis
Salmonella isolation from fecal samples, overshoe samples and
ileocecal lymph nodes was based on ISO 6579:2002/Amd1:2007 Annex
D. Fecal samples were weighed and diluted 1:10 in buffered peptone
water (BPW). The plastic bags containing the overshoes were filled with
225mL BPW and manually mixed to make sure the overshoes were
completely under water. All ileocecal lymph nodes were rinsed with
ethanol and briefly flamed to decontaminate the surface. Thereafter
they were sliced, diluted 1:10 in BPW and homogenized with a sto-
macher blender for 60 s. After non-selective pre-enrichment, 100 μL of
each BPW-solution was spotted on Modified semi-solid Rappaport-
Vassiliadis agar plates (MSRV) in three drops. From all positive MSRV
plates, a loopful from the edge of a typical migration zone was streaked
onto a xylose lysine deoxycholate agar plate (XLD) and a brilliant green
agar plate (BGA). From each plate with Salmonella presumptive co-
lonies, one of the suspected colonies was selected and inoculated in
triple sugar iron agar and lysine decarboxylase broth. From each
Salmonella positive test, a loopful from the lysine decarboxylase broth
was streaked on BGA plates to obtain Salmonella isolates for further
analysis.
Salmonella isolates were serotyped either classically (slide-aggluti-
nation), or with a multiplex-PCR for identification of Salmonella genus
and Salmonella Typhimurium (Aabo et al., 1993; Lin and Tsen, 1999)
followed by a repetitive-element PCR (Rasschaert et al., 2005) to dis-
criminate the isolates at serotype level. A 41-plex Ligase Chain Reaction
(LCR) assay followed by detection on a bead-array platform (Luminex®
200 TM) (Boland, 2014) was used to identify the serotypes. Only for
the isolates serotyped by slide agglutination, a differentiation between
the monophasic variants of Salmonella Typhimurium and diphasic Sal-
monella Typhimurium could be made. Therefore, all identified mono-
phasic Salmonella Typhimurium variants were classified as Salmonella
Typhimurium for the analysis of the results.
To distinguish Salmonella Typhimurium field strains from the vac-
cine strain, all Salmonella Typhimurium isolates were tested using the
Salmonella Diagnostic Kit® (IDT Biologika). This kit, containing two
fluid media (A and B), is based on the growth requirements of the
histidine-adenine auxotrophic vaccine strain. The vaccine strain will
only grow in medium B, containing histidine and adenine, whereas
wild-type Salmonella strains will grow in both medium A and medium
B.
To confirm the presence of the vaccine strain and to identify dif-
ferent Pulsed-Field Gel-Electrophoresis (PFGE)-profiles, all Salmonella
Typhimurium isolates were additionally analyzed by PFGE with the
XbaI restriction enzyme (PulseNet, 2017). The fingerprints were ana-
lyzed using BioNumerics (version 7.5) using Salmonella Braenderup
H9812 restricted with XbaI as the normalization reference. The simi-
larities between the fingerprints were calculated using the band-based
Dice coefficient, with an optimization and band tolerance of 1%. The
fingerprints were grouped according to their similarities using UPGMA
with a delineation level of 98%.
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2.6. Statistical analysis
The results (Salmonella Typhimurium field strain positive/negative)
of the fecal and overshoe samples collected in the sows were analyzed
in a logistic regression model, in which farm and experimental group
were included as fixed effects. The results (Salmonella Typhimurium
field strain positive/negative) of the fecal and overshoe samples col-
lected in the growing and fattening pigs (sampling moments cycle 1:
day 24, 10 weeks, 11–12 weeks, 14–15 weeks, 18 weeks and 26 weeks,
sampling moments cycle 2: day 24 and 26 weeks), were analyzed using
a logistic regression model with farm, production cycle and experi-
mental group included as fixed effects. The results (Salmonella
Typhimurium field strain positive/negative) of the ileocecal lymph
nodes were also analyzed using a logistic regression model with farm,
production cycle and experimental group included as fixed effects. The
daily weight gain during the fattening period was analyzed using a
linear regression model with farm, production cycle and experimental
group included as fixed effects. The least significant difference (LSD)-
procedure was used for post-hoc-testing to detect differences between
the different vaccinated groups and the non-vaccinated control group.
All regression models were built using stepwise backward elimina-
tion, also considering possible interactions. All statistical analyses were
performed in SPSS Statistics (version 25). P-values< 0.05 were con-
sidered statistically significant.
3. Results
3.1. Fecal and overshoe samples: sows
The bacteriological results of the fecal and overshoe samples from
the sows are shown in Table 2. In total, 41/875 (4.7%) samples were
Salmonella positive; 12/265 (4.5%), 24/299 (8.0%) and 5/311 (1.6%)
samples from farm A, B and C, respectively. The vaccine strain was
detected in 32/875 (3.7%) samples, collected in all three farms, both
from vaccinated and from non-vaccinated sow groups. In total, 6/875
(0.69%) samples were Salmonella Typhimurium field strain positive; 1/
265 (0.38%), 5/299 (1.7%) and 0/311 (0%) samples in farm A, B and C,
respectively. No significant differences were detected between farms
and experimental groups.
3.2. Fecal and overshoe samples: growing and fattening pigs
The bacteriological results of the fecal and overshoe samples from
the growing and fattening pigs in production cycle 1 are shown in
Table 3. In total, 105/791 (13.3%) samples were Salmonella positive;
45/264 (17.0%), 22/263 (8.4%) and 38/264 (14.4%) samples from
farm A, B and C, respectively. The vaccine strain was detected in 41/
791 (5.18%) samples; in 7, 8, 7, 14, 4 and 1 samples from the pigs in
experimental group 1, 2, 3, 4, 5 and 6, respectively. In total, 39/791
(4.9%) samples were Salmonella Typhimurium field strain positive; 9/
264 (3.4%), 14/263 (5.3%) and 16/264 (6.1%) samples in farm A, B
and C, respectively.
The bacteriological results of the fecal and overshoe samples from
the growing and fattening pigs in production cycle 2 are shown in
Table 4. In total, 37/306 (12.1%) samples were Salmonella positive; 23/
102 (22.5%), 5/102 (4.9%) and 9/102 (8.8%) samples from farm A, B
and C, respectively. The vaccine strain was detected in 7/306 (2.3%)
samples; in 0, 1, 2, 3, 1, 0 samples from the pigs in experimental group
1, 2, 3, 4, 5 and 6, respectively. In total, 13/306 (4.2%) samples were
Salmonella Typhimurium field strain positive; 5/102 (4.9%), 5/102
(4.9%) and 3/102 (2.9%) samples in farm A, B and C, respectively.
The percentage of Salmonella Typhimurium field strain positive
fecal and overshoe samples collected from the growing and fattening
pigs in farm A, B and C in production cycle 1 and 2 are shown in Fig. 1.
In total, 52/1097 (4.7%) samples were Salmonella Typhimurium field
strain positive. The percentage of Salmonella Typhimurium field strain
positive samples for experimental groups 1, 2, 3, 4, 5 and 6 was 5%,
3%, 3%, 8%, 5% and 4%, respectively. No significant differences were
Table 2
Bacteriological results (Salmonella spp., Salmonella Typhimurium, vaccine strain and Salmonella Typhimurium field strain) of the fecal and
overshoe samples collected from the sows in the different experimental groups1 on farm A, B and C in production cycle 1.
Next to Salmonella Typhimurium, Salmonella Rissen was detected in farm A (overshoe samples collected in the gestation unit and the
insemination unit) and Salmonella Livingstone was detected in farm B (fecal sample from a sow in the farrowing unit). In farm C, no other
serotypes than Salmonella Typhimurium were detected.
Shaded boxes indicate the presence of Salmonella Typhimurium field strain.
1 Group 1: vaccination of sows, group 2: vaccination of sows and piglets, group 3: vaccination of sows and fattening pigs, group 4:
vaccination of piglets, group 5: vaccination of fattening pigs, group 6: non-vaccinated control group. Sows, piglets and fattening pigs were
vaccinated against Salmonella Typhimurium with an attenuated histidine-adenine auxotrophic vaccine (Salmoporc®, IDT Biologika).
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detected between farms, cycles and experimental groups.
3.3. Ileocecal lymph nodes
The bacteriological results of the ileocecal lymph nodes collected at
slaughter are shown in Table 5. In Fig. 2, the percentage of Salmonella
Typhimurium field strain positive lymph nodes in both production cy-
cles is shown graphically. In production cycle 1, due to practical issues
during the slaughter of the pigs in farm B, the aimed number of ileo-
cecal lymph nodes was not collected for all experimental groups. In
production cycle 2, the aimed number of ileocecal lymph nodes was
collected for all experimental groups.
In production cycle 1, in total, 326/1098 (29.7%) lymph nodes were
Salmonella positive; 285/576 (49.5%), 2/74 (2.7%) and 39/448 (8.7%)
lymph nodes from farm A, B and C, respectively. In total, 53/1098
(4.8%) lymph nodes were Salmonella Typhimurium field strain positive;
17/576 (3.0%), 2/74 (2.7%) and 34/448 (7.6%) samples in farm A, B
and C, respectively. The percentage of Salmonella Typhimurium field
strain positive lymph nodes in experimental groups 1, 2, 3, 4, 5 and 6,
was 2%, 2%, 5%, 10%, 4% and 4%, respectively.
In production cycle 2, in total, 226/1430 (15.8%) lymph nodes were
Salmonella positive; 75/499 (15.0%), 30/404 (7.4%) and 121/527
(23.0%) lymph nodes from farm A, B and C, respectively. In total, 167/
1430 (11.7%) lymph nodes were Salmonella Typhimurium field strain
positive; 32/499 (6.4%), 19/404 (4.7%) and 116/527 (22.0%) samples
in farm A, B and C, respectively. The percentage of Salmonella
Typhimurium field strain positive lymph nodes in experimental groups
1, 2, 3, 4, 5 and 6, was 26%, 5%, 9%, 7%, 10% and 14%, respectively.
In total, in both production cycles 220/2528 (8.7%) lymph nodes
were Salmonella Typhimurium field strain positive; 49/1075 (4.6%),
21/478 (4.4%) and 150/975 (15.4%) lymph nodes in farm A, B and C,
respectively. The percentage of Salmonella Typhimurium field strain
positive lymph nodes in experimental groups 1, 2, 3, 4, 5 and 6, was
16%, 3%, 7%, 9%, 8% and 10%, respectively. Significant differences
were detected between the farms (p≤0.001), cycles (p=0.002) and
experimental groups (p≤0.001). The odds ratios for farm A and B,
compared to farm C, were 0.2 (95% CI: 0.2−0.3) and 0.2 (95% CI:
0.1−0.3), respectively. The odds ratio for production cycle 1, com-
pared to production cycle 2, was 0.3 (95% CI: 0.1−0.6). The differ-
ences between the experimental groups were independent of farm, but
related to cycle (significant interaction between cycle and experimental
group, p≤0.001). The results of the logistic regression analysis re-
garding the differences between experimental groups are shown in
Table 5. In cycle 1, no significant differences were detected between
experimental groups 1, 2, 3, 4, 5 and the control group. In cycle 2,
compared to the control group, the number of pigs positive for Salmo-
nella Typhimurium field strain was significantly higher in experimental
group 1 and significantly lower in experimental groups 2, 3 and 4. The
odds ratios for experimental group 1, 2, 3 and 4 were 2.3 (95% CI:
1.4–3.7, p= 0.001), 0.3 (95% CI: 0.1−0.6, p≤ 0.001), 0.5 (95% CI:
0.3−0.9, p= 0.014) and 0.4 (95% CI: 0.2−0.8, p=0.009), respec-
tively. No significant difference was detected between experimental
group 5 and the non-vaccinated control group.
3.3.1. Detection of vaccine strain
In total, the vaccine strain was detected in 13/2528 (0.51%) lymph
nodes. Vaccine strain positive lymph nodes were originating from the
pigs in farm A and C. None of the lymph nodes from farm B tested
positive for the vaccine strain. Of the 13 vaccine strain positive lymph
nodes, 12 were originating from pigs that had been vaccinated (12/
1729=0.69%) and one from a pig that had not been vaccinated, but
was born from a vaccinated sow (1/375=0.27%). None of the lymph
Table 3
Bacteriological results (Salmonella spp., Salmonella Typhimurium, vaccine strain and Salmonella Typhimurium field strain) of the fecal
and overshoe samples collected from the growing and fattening pigs in the different experimental groups1 on farm A, B and C in
production cycle 1.
*: in farm B, due to practical reasons, some of the pigs from group 1+ 3 and 5+6 were housed together during the nursery period.
The results of the combined samplings are given for both groups. For the total number of (positive) samples, the numbers are divided
by two.
On farm A, at 26 weeks of age, Salmonella Derby was detected in 15 fecal samples and 11 overshoe samples. On farm B and C, no other
serotypes than Salmonella Typhimurium were detected.
Shaded boxes indicate the presence of Salmonella Typhimurium field strain.
1 Group 1: vaccination of sows, group 2: vaccination of sows and piglets, group 3: vaccination of sows and fattening pigs, group 4:
vaccination of piglets, group 5: vaccination of fattening pigs, group 6: non-vaccinated control group. Sows, piglets and fattening pigs
were vaccinated against Salmonella Typhimurium with an attenuated histidine-adenine auxotrophic vaccine (Salmoporc®, IDT
Biologika).
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nodes from the pigs in the non-vaccinated control group was vaccine
strain positive.
3.4. Pulsed-field gel-electrophoresis (PFGE)
In total, seven different PFGE-profiles, including the vaccine strain
(profile A), were detected within the Salmonella Typhimurium isolates.
In Table 6, the different PFGE-profiles and the number of samples with
the different profiles are shown for each farm and each production
cycle. On each farm, next to the vaccine strain, two different Salmonella
Typhimurium PFGE-profiles were detected. Except for one lymph node
from farm C, the PFGE-profiles of Salmonella Typhimurium field strains
detected in the ileocecal lymph nodes were the same as the PFGE-
profiles of Salmonella Typhimurium field strains detected in the fecal
and overshoe samples. No difference between PFGE-profiles present in
vaccinated and non-vaccinated pigs could be detected.
PFGE confirmed the results obtained with the Salmonella Diagnostic
Kit® for all vaccine strain isolates detected (93/93 (100%)).
3.5. Daily weight gain during fattening period
The average daily weight gain of the pigs during the fattening
period in all three farms in both production cycles is shown graphically
in Fig. 3.
When combining the results of farm A, B and C and production cycle
1 and 2, the average daily weight gain of the pigs in experimental
groups 1, 2, 3, 4, 5 and 6, was 0.776, 0.793, 0.763, 0.783, 0.757 and
0.784 kg/day, respectively. Significant differences were detected be-
tween the farms (p≤0.001), cycles (p≤0.001) and experimental
groups (p≤0.001). The differences between the experimental groups
were related to farm and cycle. The daily weight gain of the vaccinated
fattening pigs (experimental group 3 and 5) was, on average, sig-
nificantly lower compared to the daily weight gain of the non-vacci-
nated control group. No significant differences were detected between
experimental groups 1, 2, 4 and the non-vaccinated control group.
4. Discussion
The current study investigated the effect of different vaccination
strategies against Salmonella Typhimurium with an attenuated vaccine
on the excretion of Salmonella and the number of pigs positive for
Salmonella in the ileocecal lymph nodes in three subclinically infected
pig herds. In production cycle 2, the results showed a protective effect
of vaccination on the number of Salmonella Typhimurium field strain
positive lymph nodes when applying vaccination either in sows and
piglets, sows and fattening pigs, or in piglets only. In production cycle
1, the protective effect was absent.
The farms included in the study were selected based on the presence
Table 4
Bacteriological results (Salmonella spp., Salmonella Typhimurium, vaccine strain and Salmonella
Typhimurium field strain) of the fecal and overshoe samples collected three days after farrowing
and from the growing and fattening pigs in the different experimental groups1 on farm A, B and
C in production cycle 2.
*: in farm B, due to practical reasons, some of the pigs from group 5+ 6 were housed together
during the nursery period. The results of the combined samplings are given for both groups. For
the total number of (positive) samples, the numbers are divided by two.
On farm A, at 26 weeks of age, Salmonella Derby was detected in eight fecal samples and eight
overshoe samples. In farm B and C, no other serotypes than Salmonella Typhimurium were de-
tected.
Shaded boxes indicate the presence of Salmonella Typhimurium field strain.
1 Group 1: vaccination of sows, group 2: vaccination of sows and piglets, group 3: vaccination
of sows and fattening pigs, group 4: vaccination of piglets, group 5: vaccination of fattening pigs,
group 6: non-vaccinated control group. Sows, piglets and fattening pigs were vaccinated against
Salmonella Typhimurium with an attenuated histidine-adenine auxotrophic vaccine
(Salmoporc®, IDT Biologika).
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of Salmonella Typhimurium and high Salmonella-specific antibody levels
in fattening pigs, without clinical Salmonella infections. Since most
Salmonella Typhimurium infections are subclinical, the farms were
considered to be good representatives for most Salmonella
Typhimurium infected farms. In the current study, the prevalence of
Salmonella excretion was comparable to a previous vaccination study on
three Belgian farrow-to-finish farms with high Salmonella-specific an-
tibody levels in fattening pigs (De Ridder et al., 2014). The prevalence
of Salmonella Typhimurium field strain excretion was low; in total, 4%
of the fecal and overshoe samples collected in the non-vaccinated
control group were Salmonella Typhimurium field strain positive. Bio-
logical variation in the Salmonella infection and excretion pattern be-
tween successive batches in a farm (Funk et al., 2001; Kranker et al.,
2003; Rajiċ et al., 2005; Wales et al., 2009), might be an explanation for
the relatively low excretion during the trial. Next to this, the presence
of different Salmonella serotypes might have influenced the detection of
Salmonella Typhimurium (Garrido et al., 2014). Different serotypes, and
possibly also the vaccine strain, may have different growth patterns
during isolation (Harvey and Price, 1967; Singer et al., 2009) and can
overgrow or camouflage the presence of Salmonella Typhimurium. In
farm A, a large number of samples collected at 26 weeks of age and
lymph nodes were Salmonella Derby positive in both production cycles.
This might have decreased the detection of Salmonella Typhimurium
field strain.
Although no significant difference was detected between the dif-
ferent farms, the excretion of Salmonella Typhimurium field strain
seemed to follow a different pattern on farm B, compared to farm A and
Fig. 1. Percentage of Salmonella Typhimurium field strain positive fecal and
overshoe samples collected from the growing and fattening pigs in the different
experimental groups1 on farm A, B and C in production cycle 1 and 2.
1Group 1: vaccination of sows, group 2: vaccination of sows and piglets, group
3: vaccination of sows and fattening pigs, group 4: vaccination of piglets, group
5: vaccination of fattening pigs, group 6: non-vaccinated control group. Sows,
piglets and fattening pigs were vaccinated against Salmonella Typhimurium
with an attenuated histidine-adenine auxotrophic vaccine (Salmoporc®, IDT
Biologika).
Sampling moments production cycle 1: day 24, 10 weeks, 11–12 weeks, 14–15
weeks, 18 weeks, 26 weeks.
Sampling moments production cycle 2: day 24, 26 weeks.
In the logistic regression model, no significant differences were detected be-
tween farms, cycles and experimental groups.
Table 5
Bacteriological (Salmonella spp., Salmonella Typhimurium, vaccine strain and Salmonella Typhimurium field strain) and
statistical (odds-ratios, confidence interval odds ratios and p-values) results of the ileocecal lymph nodes collected from
the different experimental groups1 on farm A, B and C in production cycle 1 and 2.
In production cycle 1, next to Salmonella Typhimurium, Salmonella Derby (263 lymph nodes) and Salmonella
Montevideo (2 lymph nodes) were detected in farm A and Salmonella Livingstone (one lymph node) was detected in
farm C. In farm B, no other serotypes than Salmonella Typhimurium were detected. In production cycle 2, next to
Salmonella Typhimurium, Salmonella Derby (42 lymph nodes) was detected in farm A and Salmonella Enteritidis (11
lymph nodes) was detected in farm B. In farm C, no other serotypes than Salmonella Typhimurium were detected.
1 Group 1: vaccination of sows, group 2: vaccination of sows and piglets, group 3: vaccination of sows and fattening
pigs, group 4: vaccination of piglets, group 5: vaccination of fattening pigs, group 6: non-vaccinated control group.
Sows, piglets and fattening pigs were vaccinated against Salmonella Typhimurium with an attenuated histidine-adenine
auxotrophic vaccine (Salmoporc®, IDT Biologika).
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C, in the first production cycle. In farm B, several samples collected in
the nursery (day 24 and 10 weeks of age) and none of the samples
collected at 18 and 26 weeks of age was Salmonella Typhimurium po-
sitive, whereas this was the other way around in farms A and C. In
previous research, variable patterns of Salmonella prevalence and ex-
cretion have been described between farms, within cohorts over time
and among cohorts within farms/systems (Funk et al., 2001; Kranker
et al., 2003; Rajiċ et al., 2005; Wales et al., 2009). Also, the apparent
clearance of infection in pigs which excreted Salmonella in the nursery
has been described (Kranker et al., 2003).
Salmonella-positive pigs entering the slaughterhouse have been identi-
fied as a potential risk for carcass contamination during slaughter (Berends
et al., 1997; Botteldoorn et al., 2004). Although farm infections have been
proposed to be an important predictor of Salmonella prevalence at slaughter
(Bahnson et al., 2005), several studies have described the importance of
transport and lairage as a possible source of Salmonella in slaughter pigs
(Morgan et al., 1987; Hurd et al., 2001; De Busser et al., 2011; Kich et al.,
2011; Wilhelm et al., 2017). In the current study, Salmonella Montevideo
(farm A), Salmonella Enteritidis (farm B) and Salmonella Livingstone (farm
C) were only detected in the lymph nodes, and not in the fecal and overshoe
samples collected on the corresponding farms. The detection of these ser-
otypes might be the result of infections acquired during transport or lairage
(> two hours for most pigs in the current study), as several different tissues,
including ileocecal lymph nodes, can be Salmonella positive within 2–4 h
after experimental Salmonella infection (Blaha et al., 1997) or exposure to an
environment highly contaminated with Salmonella (Boughton et al., 2007).
Since the vast majority of PFGE-profiles from Salmonella Typhimurium
isolates collected at slaughter corresponded to the PFGE-profiles from the
Salmonella Typhimurium isolates collected at the farm, new Salmonella
Typhimurium infections acquired during transport or lairage have probably
not significantly influenced the results of the present study.
The significant differences between the vaccinated groups in the
number of Salmonella Typhimurium field strain positive lymph nodes
were independent of farm, but related to cycle. In the first production
cycle, no significant differences were detected. In the second produc-
tion cycle, however, compared to the non-vaccinated control group, a
protective effect of vaccination of sows and piglets, sows and fattening
pigs and piglets only was detected. The percentage of Salmonella
Typhimurium field strain positive lymph nodes collected from the non-
vaccinated control group in production cycle 1 and 2 was 4% and 14%,
respectively. Biological variation in the Salmonella infection pattern
between successive batches in a farm (Funk et al., 2001; Kranker et al.,
Fig. 3. Average daily weight gain of the pigs in the different experimental
groups1 during the fattening period in production cycle 1 and 2.
1Group 1: vaccination of sows, group 2: vaccination of sows and piglets, group
3: vaccination of sows and fattening pigs, group 4: vaccination of piglets, group
5: vaccination of fattening pigs, group 6: non-vaccinated control group. Sows,
piglets and fattening pigs were vaccinated against Salmonella Typhimurium
with an attenuated histidine-adenine auxotrophic vaccine (Salmoporc®, IDT
Biologika).
The pigs were weighed individually at 10–12 weeks of age and 24–26 weeks of
age.
Experimental groups significantly different from the non-vaccinated control
group in the linear regression model (combined analysis of farm A, B and C in
production cycle 1 and 2) are indicated with **.
Table 6
Different PFGE-profiles1 detected in the fecal and overshoe
samples and ileocecal lymph nodes collected in farm A, B,
and C in production cycle 1 and 2.
1 PFGE-profile A: vaccine strain.
Fig. 2. Percentage of Salmonella Typhimurium field strain positive ileocecal
lymph nodes from the different experimental groups1 in production cycle 1 and
production cycle 2.
1Group 1: vaccination of sows, group 2: vaccination of sows and piglets, group
3: vaccination of sows and fattening pigs, group 4: vaccination of piglets, group
5: vaccination of fattening pigs, group 6: non-vaccinated control group. Sows,
piglets and fattening pigs were vaccinated against Salmonella Typhimurium
with an attenuated histidine-adenine auxotrophic vaccine (Salmoporc®, IDT
Biologika).
Experimental groups significantly different from the non-vaccinated control
group in the logistic regression model are indicated with **.
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2003; Rajiċ et al., 2005; Wales et al., 2009) might be an explanation for
the difference between the production cycles. The difference between
both production cycles emphasizes the importance of investigating
different successive batches within a farm when implementing control
measures against Salmonella. In the case of sow vaccination against
Salmonella Typhimurium, the excretion and environmental prevalence
of Salmonella might only be reduced substantially one year after the
start of vaccination (Smith et al., 2018).
In previous research, after the application of the same attenuated vac-
cine in sows and gilts in farms experiencing clinical salmonellosis related
with Salmonella Typhimurium or Salmonella Typhimurium monophasic
variants, the clinical problems resolved and the excretion of Salmonella
Typhimurium was markedly and persistently reduced (Davies et al., 2016).
In the current study, in subclinically infected herds, vaccination of sows only
did not reduce the excretion of Salmonella Typhimurium field strains, nor
the number of Salmonella Typhimurium field strain positive lymph nodes in
slaughter pigs. Compared to the non-vaccinated control group, a sig-
nificantly higher number of Salmonella Typhimurium field strain positive
lymph nodes was detected in the fattening pigs from experimental group 1
(vaccination of sows only). The exact reason for this is not clear. Possibly,
the increased level of maternally derived Salmonella antibodies in piglets
from vaccinated sows (Peeters et al., 2017), might have resulted in a de-
layed or altered active immune response of the piglets (Salmon et al., 2009).
Vaccination of fattening pigs only did not have a significant effect
on the number of Salmonella Typhimurium field strain positive lymph
nodes compared to the non-vaccinated control group, whereas vacci-
nation of piglets only did have a protective effect. To maximize effects
on colonization, vaccination should be applied before exposure to
Salmonella (Wales and Davies, 2017). Some fattening pigs might have
been colonized by Salmonella Typhimurium before vaccination, which
might explain the limited effect of vaccination.
The odds ratio for lymph nodes being Salmonella Typhimurium field
strain positive, compared to the non-vaccinated control group, was
0.270 in case of vaccination in sows and piglets. This odds ratio in-
dicates a strong association of the vaccination strategy and the number
of Salmonella Typhimurium field strain positive lymph nodes of the
fattening pigs at slaughter age, whereas the odds ratios in the case of
vaccination of sows (2.270), vaccination of sows and fattening pigs
(0.480) and vaccination of piglets only (0.439) indicate moderate as-
sociations (Monson, 1990). These results are comparable to previous
research with an inactivated Salmonella Typhimurium monophasic
variant vaccine (Ruggeri et al., 2015). Ruggeri et al. (2015) concluded
that the most consistent reduction of excretion and tissue contamina-
tion at slaughter was detected after vaccination of both sows (six and
two weeks before farrowing) and pigs (four and eight weeks of age),
whereas the vaccination of either sows or pigs resulted in more variable
results (Ruggeri et al., 2015).
Vaccination of fattening pigs (experimental group 3 and 5) resulted in a
significantly lower daily weight gain during the fattening period compared
to the non-vaccinated control group (0.763 and 0.757 versus 0.784 kg/day).
Although no adverse reactions (e.g. loss of appetite, huddling) were reported
by the farmers, according to the product characteristics of the vaccine, a
temporary increase of the body temperature can take place. This, together
with the shift in metabolic priorities in order to develop an immune re-
sponse (Patience et al., 2015), might explain the lower daily weight gain
during the fattening period.
In the current trial, next to the vaccine strain, only two different
Salmonella Typhimurium PFGE-profiles were detected in the samples
collected from each farm. These results, showing a rather limited ge-
netic variation within a farm, are comparable to previous research,
detecting only one or two different dominant Salmonella Typhimurium
PFGE-profiles in samples from pigs and the environment per farm
(Sandvang et al., 2000; Magistrali et al., 2008). Although PFGE analysis
has some limitations, e.g. providing less detailed information compared
to whole genome sequencing, currently, it is considered the “gold
standard” for genotyping Salmonella (Ferrari et al., 2017).
The vaccine strain was detected in samples collected in the sows as
well as in the growing and fattening pigs. In farm A and B, the samples
which were collected from the sows six weeks before farrowing were,
for practical reasons, partially collected during or directly after the
vaccination. Contamination of samples or the environment might have
caused the detection of vaccine strain at this sampling moment. Also for
the other sampling moments, contamination of the environment, as
well as transfer of the vaccine strain by the boots of the farmer and
transfer by means of nose-to-nose contact with pigs in adjacent pens
might have resulted in vaccine strain positive samples in experimental
groups of pigs that were not vaccinated. In the growing and fattening
pigs of the non-vaccinated control group, only one sample (overshoe
sample, collected at 18 weeks of age in farm C) was vaccine strain
positive. According to the product characteristics of Salmoporc®, the
vaccine strain can be excreted until 42 days after vaccination. In the
current study, at 26 weeks of age, approximately 77–84 days after the
last vaccination, none of the fecal and overshoe samples were vaccine
strain positive. The vaccine strain was, however, detected in the lymph
nodes of 13 pigs at slaughter (26–29 weeks of age): 12 pigs that had
been vaccinated (12/1729=0.69%) and one pig that had not been
vaccinated, but was born from a vaccinated sow.
Previous results regarding the possible persistence of the vaccine
strain are inconsistent. In the field study of Lindner et al. (2007), none
of the Salmonella Typhimurium isolates collected from ileocecal lymph
nodes of 484 vaccinated pigs (born from sows subcutaneously vacci-
nated at six and three weeks before farrowing, vaccinated orally at 21
and 42 days of age) were positive for the vaccine strain (Lindner et al.,
2007). In the field study of De Ridder et al. (2014), the vaccine strain
was detected in fecal samples throughout the fattening period and in
ileocecal lymph nodes and cecal contents collected at slaughter after
oral vaccination of piglets at three and 24 days of age (De Ridder et al.,
2014). Since the pathogenicity of the attenuated vaccine strain for
humans has not been investigated (De Ridder et al., 2014), detection of
the vaccine strain at slaughter might pose a risk for public health. Also,
since extra tests are needed to distinguish Salmonella field strains from
the attenuated vaccine strain, persistence of the vaccine strain until
slaughter may have implications for Salmonella monitoring programs
based on Salmonella detection in slaughterhouse samples.
The results of the current study should be extrapolated with care
because of limitations in the study design, and the variability between
farms and production cycles. In observational field studies (as the
current study), the possible presence of untested risk factors and the
occurrence of practical issues and lower than expected prevalence (e.g.
collection and results of ileocecal lymph nodes from production cycle
1), cannot be excluded and might influence the results. Also, the se-
paration of experimental groups inherently implied that the experi-
mental groups were not randomized and that the comparability of pigs
in the non-vaccinated control group and vaccinated groups could not be
evaluated and demonstrated. Next to this, the incomplete separation of
experimental groups in the current study (e.g. nose-to-nose contact with
pigs in adjacent pens) might have influenced the results.
Based on the outcomes of this study, it is not possible to give vac-
cination advise that applies for all farms under all circumstances.
Nevertheless, the results of the current field study provide evidence that
applying vaccination against Salmonella Typhimurium in sows and
piglets (preferred), sows and fattening pigs, and piglets only can sup-
port the control of Salmonella Typhimurium infections in pigs by de-
creasing the prevalence of Salmonella Typhimurium field strain positive
lymph nodes at slaughter.
5. Conclusion
The results of the current study should, because of limitations in the
study design and the variability between the farms and production
cycles, be extrapolated with care. Nevertheless, they provide evidence
that applying vaccination against Salmonella Typhimurium in sows and
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piglets (preferred), sows and fattening pigs, and piglets only can sup-
port the control of Salmonella Typhimurium infections by decreasing
the prevalence of Salmonella Typhimurium field strain positive lymph
nodes at slaughter. The possible persistence of the vaccine strain until
slaughter may have implications for Salmonella monitoring programs
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